Subjects: Medicine, Pharmacy >> Clinical Medicine submitted time 2022-07-29 Cooperative journals: 《中国全科医学》
Abstract： Schizophrenia is a chronic，recurrent and disabling psychotic disorder. Enhancing patient adherence and preventing recurrence are the key factors of treating schizophrenia, and the core determinants of prognosis and social functional recovery of these patients. Recommended by guidelines/consensuses as one treatment for schizophrenia, long-acting injectable（LAI）antipsychotics have been an important intervention for treating schizophrenia and for preventing its recurrence, At the same time，as community settings are important sites for the rehabilitation of schizophrenia， considerable efforts have been made to explore models of community-based management of schizophrenia. Currently, the use of LAI antipsychotics in community-based management of schizophrenia has been highlighted in multiple policies and documents of China, but its application is negatively influenced partially by community physicians' insufficient understanding and application skills regarding LAI antipsychotics, which has become a bottleneck that hinders the comprehensive rehabilitation of schizophrenics. In view of this, a consensus was developed based on clinical evidence, previous guidelines and consensuses, expert individual practice and features of community settings in China, by a group of 13 experts, including psychiatrists from the Chinese Schizophrenia Coordination Group，Psychiatric Society, Chinese Medical Association, and general medicine experts from the Chinese Society of General Practice, Chinese Medical Association. This consensus will significantly contribute to the solving of problems in the use of LAI antipsychotics for community-based management of schizophrenia, and the improvement of patient adherence and prognosis.
Subjects: Medicine, Pharmacy >> Clinical Medicine submitted time 2022-07-22 Cooperative journals: 《中国全科医学》
Abstract： Schizophrenia is a chronic, recurrent and disabling psychotic disorder. Improving patients' adherence and preventing relapse are key factors in the treatment of schizophrenia, as well as the core factors to determine patients' prognosis and social function recovery. Long-acting injectable (LAI) is an important treatment and recurrent prevention of schizophrenia, which is recommended by guidelines/consensus as one of the preferred treatment methods for the all schizophrenia. At the same time, community as an important site for the rehabilitation of schizophrenia, some community management models have been carried out recently. At present, a series of policies and documents stressed the application of LAI in the management of schizophrenia in community. However, some community mental health workers are lack of experience and application skills of LAI, which affects the application of LAI in the community and become one of the bottlenecks for the rehabilitation of patients. Therefore, under the organization of the Chinese Schizophrenia Coordination Group and Chinese Society of General Practice, 13 experts formed the expert group members of this consensus, which based on the evidence-based medical suggestion, domestic and international guidelines and consensus, experts experience and the characteristics of Chinese community. This consensus is expected to solve medical problems in the community LAI application and improve patients compliance and prognosis of schizophrenia.
Hits
Hits
Downloads
Comment